SABS · SAB Biotherapeutics, Inc. · Earnings Call Transcripts & Audio
Market Cap
$310.26M
Shares
90.99M
SAB Biotherapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for SAB Biotherapeutics, Inc. (SABS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Earnings call
FY26 · Q2
2026-08-06
SAB Biotherapeutics, Inc. (SABS) Q2 2026 Earnings Call Transcript
Confident tone
Safeguard Phase 2b enrollment progress
PRIZE investigator-led Phase 3 study
SAB142 lead asset and mechanism
Diluted EPS
$-0.28
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-09
SAB Biotherapeutics, Inc. (SABS) March 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-02-25
SAB Biotherapeutics, Inc. (SABS) February 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Showing 1–3 of 3 earnings calls
Key facts
CIK
1833214
CUSIP
78397T202
13F (30d)
55 filings
55 filers
Visit website
Investor relations